BIOMAT Database Logo BIOMAT Database Logo

[Acute and chronic effects of dihydralazine in severe congestive heart failure at rest and during exercise (author's transl)]. 1982

N Reifart, and T Bunge, and M Kaltenbach, and W D Bussmann

UI MeSH Term Description Entries
D008134 Long-Term Care Care over an extended period, usually for a chronic condition or disability, requiring periodic, intermittent, or continuous care. Care, Long-Term,Long Term Care
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004078 Dihydralazine 1,4-Dihydrazinophthalazine. An antihypertensive agent with actions and uses similar to those of HYDRALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p354) Depressan,Dihydralazine Sulfate,Dihydrallazine,Dihydrazinophthalazin,Sulfate, Dihydralazine
D005082 Physical Exertion Expenditure of energy during PHYSICAL ACTIVITY. Intensity of exertion may be measured by rate of OXYGEN CONSUMPTION; HEAT produced, or HEART RATE. Perceived exertion, a psychological measure of exertion, is included. Physical Effort,Effort, Physical,Efforts, Physical,Exertion, Physical,Exertions, Physical,Physical Efforts,Physical Exertions
D005260 Female Females
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006830 Hydralazine A direct-acting vasodilator that is used as an antihypertensive agent. Hydrallazin,Apresoline,Apressin,Apressoline,Hydralazine Hydrochloride,Hydralazine mono-Hydrochloride,Hydrazinophthalazine,Nepresol,Hydralazine mono Hydrochloride,Hydrochloride, Hydralazine,mono-Hydrochloride, Hydralazine

Related Publications

N Reifart, and T Bunge, and M Kaltenbach, and W D Bussmann
[Hemodynamic effects of hydralazine at rest and during exercise, in patients with congestive heart failure (author's transl)].
July 1980, Revista medica de Chile,
N Reifart, and T Bunge, and M Kaltenbach, and W D Bussmann
Acute effects of intravenous indoramin on the hemodynamic adaptation at rest and during exercise in chronic congestive heart failure.
January 1986, Journal of cardiovascular pharmacology,
N Reifart, and T Bunge, and M Kaltenbach, and W D Bussmann
[Alteration in left ventricular function induced by dihydralazine in severe chronic congestive heart failure: limits of vasodilator therapy? (author's transl)].
April 1980, La Nouvelle presse medicale,
N Reifart, and T Bunge, and M Kaltenbach, and W D Bussmann
Hemodynamic effects of alinidine (ST 567) at rest and during exercise in patients with chronic congestive heart failure.
June 1990, American heart journal,
N Reifart, and T Bunge, and M Kaltenbach, and W D Bussmann
Trimazosin in chronic congestive heart failure: improved left ventricular function at rest and during exercise.
November 1983, American heart journal,
N Reifart, and T Bunge, and M Kaltenbach, and W D Bussmann
Hemodynamic effects at rest and during exercise in long-term treatment with prazosin in chronic congestive heart failure.
January 1986, Acta medica Scandinavica,
N Reifart, and T Bunge, and M Kaltenbach, and W D Bussmann
Hemodynamic responses to indoramin at rest and during exercise in congestive heart failure.
January 1987, Pharmacotherapy,
N Reifart, and T Bunge, and M Kaltenbach, and W D Bussmann
Angiotensin converting enzyme inhibition at rest and during exercise in congestive heart failure.
May 1993, European heart journal,
N Reifart, and T Bunge, and M Kaltenbach, and W D Bussmann
Plasma immunoreactive neuropeptide Y in congestive heart failure at rest and during exercise.
October 1993, Scandinavian journal of clinical and laboratory investigation,
N Reifart, and T Bunge, and M Kaltenbach, and W D Bussmann
Acute inotropic stimulation with dopamine in severe congestive heart failure: beneficial hemodynamic effect at rest but not during maximal exercise.
November 1983, The American journal of cardiology,
Copied contents to your clipboard!